Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics
August 30 2021 - 8:35AM
via NetworkNewsWire -- Microdose Psychedelic Insights, a
cutting-edge media company focused on promoting content, financial
analysis, and engaging events designed to drive the psychedelics
industry into the forefront of modern medicine, will be hosting the
upcoming DMT Conference in an entirely virtual format Sept. 9-10,
2021. The virtual event will explore the potential of DMT
(“Dimethyltryptamine”) at the intersection of drug development and
safety, clinical care, law and regulation, business and markets,
science and research.
Part of Microdose’s Molecular Masterclasses conference series, a
series of events designed to carry out educational deep dives into
the world’s favorite psychoactive and psychedelic substances, the
DMT Conference will see to venture into the dynamic field of DMT
therapeutics, with expert panels and engaging discussions.
This year’s conference will kick off with an introductory talk
from Patrick Moher, CEO of Microdose Psychedelic Insights, followed
by a series of hour-long presentations and keynote addresses.
Topics will include, “Addiction and DMT” delivered by Entheon
Biomedical; “Non-Neuropsychiatric Uses for DMT” by PharmaDrug Inc,
“DMT Drug Development” from Small Pharma INC; and a keynote
presentation by Algernon Pharmaceuticals entitled “DMT – New Hope
for Healing the Brain After a Stroke,” among various others.
The conference is organised in partnership with Entheon
Biomedical Corp. (CSE: $ENBI) (OTCQB: $ENTBF) (FSE: $1XU1), a
biotechnology company focused on developing psychedelic medicines
to treat addiction; Small Pharma (TSXV: $DMT) a neuropharmaceutical
company taking a novel approach to depression drug development;
Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF) (XFRA: AGW)
a clinical-stage drug development company focused on the disease
areas of stroke, idiopathic pulmonary fibrosis (IPF) and chronic
cough, and COVID-19; and Pharmadrug, a Biotech Company Focused on
the R&D of Natural Based Medicines.
Other presenters at the conference include Christopher
Timmermann-Slater, Andrew Hegle, Paul Van Slyke, Daniel Cohen,
Christopher Moreau, Jackie von Salm, Carol Routledge, Brian Jahns,
Natan Ponieman, Andrew Hegle Paul Van Slyke, Christopher
Timmermann-Slater Peter Rands, Graham Pechenik David Wood, Ruth
Chun, Hadas Alterman Rick Strassman MD, Timothy Ko, Brian Jahns,
Crystal Carson, Joël Brierre, Max Montrose, Tricia Eastman, Rak
Razam, Victoria Wueschner, among others.
The conference will enable attendees to build relationships,
network with professionals from across the psychedelics industry,
and discover the latest findings within psychedelic science.
Additional information about the DMT Conference, as well as
details for registration, can be found at the DMT Conference
website at https://microdose.buzz/pnwmm.
About Microdose Psychedelic Insights: Microdose
Psychedelic Insights is your guide to the psychedelic medicine
industry. With a vision to shift the world's perception of
psychedelic medicine, we distribute and create the most compelling
content, financial analysis, engaging events, and ground-breaking
education to drive the psychedelics industry to the forefront of
modern medicine.
About Microdose Molecular
Masterclasses:Microdose Molecular Masterclasses are a
speaker series designed for deep dives into the world's favorite
psychoactive and psychedelic substances. Each event will explore
one drug, and feature a curated group of industry experts and
thought leaders from around the world.
Contact: Microdose Psychedelic Insights
kristina@microdose.buzz
Media Contact: InvestorBrandNetwork
(IBN) Los Angeles, California
www.InvestorBrandNetwork.com 310.299.1717 Office
Editor@InvestorBrandNetwork.com
Small Pharma (TSXV:DMT)
Historical Stock Chart
From Nov 2024 to Dec 2024
Small Pharma (TSXV:DMT)
Historical Stock Chart
From Dec 2023 to Dec 2024